New program aims to ease the burden of head and neck cancer treatment
NCT ID NCT04617678
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests a prehabilitation program for 80 adults with head and neck cancer. The program provides personalized education and support before and during cancer treatment to improve emotional well-being, reduce distress, and enhance quality of life. Participants are compared to a control group to see if the program makes a difference.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2021
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Equal to or greater than 18 years of age * Diagnosis of head and neck cancer * Actively pursuing cancer treatment with a curative intent * Willing and able to provide written consent Exclusion Criteria: * Patients with cardiac arrhythmia with implanted pacemaker * Patients with other implanted electronic equipment/device * Patients undergoing external defibrillation * Pregnant women (per BIS instructions for use, pregnant women should not participate) * Patient weight exceeding 375 lbs. * Patient has a metal allergy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer of head and neck are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sanford Health
Fargo, North Dakota, 58104, United States
-
Sanford Health
Sioux Falls, South Dakota, 57104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New imaging technique could help doctors predict cancer treatment response
- Can less radiation be safer without sacrificing cancer control?
- New study aims to help cancer survivors manage other health problems
- Cialis and keytruda together against head and neck cancer: small trial shows promise?
- Immunotherapy combo shows promise in reducing head and neck cancer recurrence
- Immunotherapy may replace chemo in head and neck cancer trial